Analytical Data
-
Gene name
SCYL2
- Application
-
Alternative Names
CC-1; CC-3; CCL14; CCL14_HUMAN; chemokine (C-C motif) ligand 14; Chemokine CC-1/CC-3; chemokine CC1; chemokine CC3; chemokine HCC1; chemokine HCC3; CKb1; HCC 1; HCC 3; HCC-1(1-74); HCC-1(9-74); HCC-1/HCC-3; HCC-3; HCC1; HEMOFILTRATE CC CHEMOKINE 1; MCIF; NCC-2; NCC2; new CC chemokine 2; SCYA14; SCYL2; small inducible cytokine subfamily A (Cys-Cys); member 14; Small-inducible cytokine A14; SY14
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16627
-
Expression Region
22-93 aa
-
AA Sequence
TESSSRGPYH PSECCFTYTT YKIPRQRIMD YYETNSQCSK PGIVFITKRG HSVCTNPSDK WVQDYIKDMK EN
-
Molecular Weight
8.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCYL2, or SCY1-like protein 2, is a member of the SCY1-like protein family, which plays crucial roles in various cellular processes, including intracellular transport, endocytic trafficking, and membrane dynamics. Research has shown that SCYL2 is involved in the regulation of Golgi function and protein sorting, which are vital for maintaining cellular homeostasis. Mutations or dysregulation of SCYL2 have been implicated in several diseases, including neurodegenerative disorders and cancer. Understanding SCYL2 through recombinant protein studies can provide insight into its structural and functional characteristics, elucidating how it interacts with other cellular components and contributes to disease mechanisms. The recombination of SCYL2 allows for the production of large quantities of the protein, facilitating biochemical assays, structural studies, and potential therapeutic applications. Current research aims to explore the molecular pathways involving SCYL2, its roles in cellular signaling, and the impact of its aberrant function in disease contexts. By elucidating the functional properties of SCYL2, scientists hope to pave the way for novel interventions targeting its pathways, offering potential avenues for therapeutic development in conditions associated with SCYL2 dysfunction.
